Boron toxicity: Difference between revisions
Ostermayer (talk | contribs) (Created page with "==Background== *Boron toxicity results from exposure to boron-containing compounds, most commonly '''boric acid''' (H₃BO₃) and '''borax''' (sodium tetraborate decahydrate)<ref name="hadrup">Hadrup N, Frederiksen M, Sharma AK. Toxicity of boric acid, borax and other boron containing compounds: a review. ''Regul Toxicol Pharmacol''. 2021;121:104873. PMID 33485927.</ref> *Common sources of exposure: **Insecticides/pesticides (ant baits, cockroach powder — most common...") |
(Strip excess bold) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Boron toxicity results from exposure to boron-containing compounds, most commonly | *Boron toxicity results from exposure to boron-containing compounds, most commonly boric acid (H₃BO₃) and borax (sodium tetraborate decahydrate)<ref name="hadrup">Hadrup N, Frederiksen M, Sharma AK. Toxicity of boric acid, borax and other boron containing compounds: a review. ''Regul Toxicol Pharmacol''. 2021;121:104873. PMID 33485927.</ref> | ||
*Common sources of exposure: | *Common sources of exposure: | ||
**Insecticides/pesticides (ant baits, cockroach powder — most common source in the ED) | **Insecticides/pesticides (ant baits, cockroach powder — most common source in the ED) | ||
| Line 9: | Line 9: | ||
**Homemade "slime" products (borax-containing) | **Homemade "slime" products (borax-containing) | ||
*Routes: oral ingestion (most common and most dangerous), dermal (through compromised skin), inhalation (occupational dust) | *Routes: oral ingestion (most common and most dangerous), dermal (through compromised skin), inhalation (occupational dust) | ||
*Boric acid is readily absorbed from the GI tract (92–94% bioavailability); absorption through | *Boric acid is readily absorbed from the GI tract (92–94% bioavailability); absorption through intact skin is minimal, but compromised skin (burns, wounds, diaper rash) allows significant systemic absorption<ref name="hadrup"/> | ||
*Excreted primarily via the kidneys; ~50% of an oral dose eliminated within 12 hours<ref name="gasparini">Gasparini S, Donà C, Piccini E, et al. Unintentional boric acid exposure: a case report and boron level monitoring. ''Ital J Pediatr''. 2025;51:148. PMID 40399389.</ref> | *Excreted primarily via the kidneys; ~50% of an oral dose eliminated within 12 hours<ref name="gasparini">Gasparini S, Donà C, Piccini E, et al. Unintentional boric acid exposure: a case report and boron level monitoring. ''Ital J Pediatr''. 2025;51:148. PMID 40399389.</ref> | ||
*Estimated minimum lethal oral dose of boric acid:<ref name="atsdr">Agency for Toxic Substances and Disease Registry (ATSDR). ''Toxicological Profile for Boron''. Atlanta, GA: US Department of Health and Human Services; 2010.</ref> | *Estimated minimum lethal oral dose of boric acid:<ref name="atsdr">Agency for Toxic Substances and Disease Registry (ATSDR). ''Toxicological Profile for Boron''. Atlanta, GA: US Department of Health and Human Services; 2010.</ref> | ||
** | **Infants: 2–3 g | ||
** | **Children: 5–6 g | ||
** | **Adults: 15–20 g | ||
*However, a review of 784 boric acid poisonings (10–88 g ingested) found '''88% were asymptomatic''' and no fatalities, indicating significant individual variability<ref name="atsdr"/> | *However, a review of 784 boric acid poisonings (10–88 g ingested) found '''88% were asymptomatic''' and no fatalities, indicating significant individual variability<ref name="atsdr"/> | ||
*There is | *There is no specific antidote — treatment is supportive with aggressive IV hydration | ||
*Special populations at highest risk: | *Special populations at highest risk: | ||
** | **Neonates/infants: Extremely low lethal dose; historical nursery epidemics from boric acid wound care caused multiple deaths | ||
** | **Patients with renal impairment: Impaired clearance increases risk of toxic accumulation | ||
** | **Burn patients / compromised skin: Systemic absorption through damaged skin can be fatal | ||
==Clinical Features== | ==Clinical Features== | ||
===Acute Ingestion=== | ===Acute Ingestion=== | ||
* | *Gastrointestinal (earliest and most common): | ||
**Nausea, vomiting (classically | **Nausea, vomiting (classically blue-green emesis), diarrhea (may also be blue-green), abdominal pain | ||
**GI mucosal erosion/corrosive injury in large ingestions<ref name="singh">Singh H, Dhibar DP, Naidu GSRSNK. Life-threatening corrosive injury with hepato-renal-pulmonary failure in boric acid poisoning. ''Postgrad Med J''. 2022;98(1155):70-71. PMID 33472901.</ref> | **GI mucosal erosion/corrosive injury in large ingestions<ref name="singh">Singh H, Dhibar DP, Naidu GSRSNK. Life-threatening corrosive injury with hepato-renal-pulmonary failure in boric acid poisoning. ''Postgrad Med J''. 2022;98(1155):70-71. PMID 33472901.</ref> | ||
* | *Dermatologic (characteristic): | ||
**Diffuse erythematous rash on palms, soles, and buttocks — classically described as | **Diffuse erythematous rash on palms, soles, and buttocks — classically described as "boiled lobster" appearance<ref name="atsdr"/> | ||
**Skin desquamation/exfoliation (may appear 1–2 days after exposure) | **Skin desquamation/exfoliation (may appear 1–2 days after exposure) | ||
**Alopecia (with chronic exposure) | **Alopecia (with chronic exposure) | ||
* | *Neurologic (severe toxicity): | ||
**Headache, irritability, lethargy → tremor → seizures → coma | **Headache, irritability, lethargy → tremor → seizures → coma | ||
* | *Renal: Oliguria, acute renal failure | ||
* | *Hepatic: Transaminitis, hepatic injury<ref name="singh"/> | ||
* | *Cardiovascular (severe): Hypotension, cardiovascular collapse | ||
* | *Metabolic: Metabolic acidosis | ||
* | *Death results from respiratory failure, cardiovascular collapse, or multiorgan failure<ref name="atsdr"/> | ||
===Timing=== | ===Timing=== | ||
*GI symptoms typically appear within 1–4 hours of ingestion | *GI symptoms typically appear within 1–4 hours of ingestion | ||
* | *If asymptomatic at 4 hours post-ingestion, significant toxicity from a single acute ingestion is unlikely | ||
*Dermatologic findings may be delayed 1–2 days | *Dermatologic findings may be delayed 1–2 days | ||
| Line 63: | Line 63: | ||
==Evaluation== | ==Evaluation== | ||
===Workup=== | ===Workup=== | ||
* | *Fingerstick glucose — all patients with altered mental status | ||
* | *BMP/CMP: Electrolytes, BUN/creatinine (renal function), glucose, bicarbonate (acidosis), liver enzymes | ||
* | *CBC | ||
* | *ABG/VBG: If metabolic acidosis suspected | ||
* | *Urinalysis: Assess renal function | ||
* | *ECG: Baseline; monitor for dysrhythmias | ||
* | *CXR: If respiratory symptoms present | ||
* | *Acetaminophen, salicylate levels: Screen for co-ingestants in all intentional ingestions | ||
* | *Serum boron level: | ||
**Can confirm exposure but is | **Can confirm exposure but is not widely available in most EDs | ||
** | **Should NOT guide acute management — treat based on clinical presentation<ref name="gasparini"/> | ||
**Levels > 340 μg/mL have been associated with fatalities | **Levels > 340 μg/mL have been associated with fatalities | ||
* | *Endoscopy: Consider if large ingestion with suspected corrosive injury to esophagus/stomach (consult GI)<ref name="singh"/> | ||
===Diagnosis=== | ===Diagnosis=== | ||
*Diagnosis is primarily | *Diagnosis is primarily clinical — based on history of exposure and characteristic findings (blue-green emesis, "boiled lobster" rash, GI symptoms) | ||
*Serum boron levels confirm exposure but do not correlate reliably with severity and should not delay treatment | *Serum boron levels confirm exposure but do not correlate reliably with severity and should not delay treatment | ||
* | *Activated charcoal does NOT effectively adsorb boric acid — a negative charcoal response does not exclude the diagnosis<ref name="hadrup"/> | ||
*Standard urine drug screens do not detect boron compounds | *Standard urine drug screens do not detect boron compounds | ||
*Consider boron toxicity in unexplained erythroderma + GI symptoms, particularly in neonates/infants or patients with occupational/household exposure history | *Consider boron toxicity in unexplained erythroderma + GI symptoms, particularly in neonates/infants or patients with occupational/household exposure history | ||
==Management== | ==Management== | ||
* | *Airway: Protect if altered mental status; intubate for respiratory failure | ||
* | *IV fluid resuscitation: This is the most important intervention — aggressive hydration enhances renal boron excretion (primary elimination pathway)<ref name="gasparini"/> | ||
**Target urine output > 2 mL/kg/hr | **Target urine output > 2 mL/kg/hr | ||
* | *Continuous cardiac monitoring and pulse oximetry | ||
* | *GI decontamination: | ||
** | **Activated charcoal is NOT effective for boric acid (poorly adsorbed)<ref name="hadrup"/> | ||
** | **Gastric lavage: Consider only for massive recent ingestions (within 1 hour) in symptomatic patients; not routinely recommended | ||
** | **Whole bowel irrigation: May be considered for very large ingestions; limited evidence | ||
* | *Dermal decontamination: Thorough irrigation with copious water; remove contaminated clothing | ||
* | *Seizures: Benzodiazepines (lorazepam 0.1 mg/kg IV, or diazepam) | ||
* | *Hypotension: IV fluid bolus; vasopressors (norepinephrine) if refractory | ||
* | *Metabolic acidosis: Sodium bicarbonate if pH < 7.1 or hemodynamically significant | ||
* | *Hemodialysis:<ref name="atsdr"/> | ||
**Effectively removes boron (small molecule, low protein binding, low volume of distribution) | **Effectively removes boron (small molecule, low protein binding, low volume of distribution) | ||
** | **Indications: Massive ingestion, renal failure limiting excretion, severe or worsening toxicity despite supportive care | ||
**Consider early in severe cases rather than as a rescue measure | **Consider early in severe cases rather than as a rescue measure | ||
==Disposition== | ==Disposition== | ||
* | *Discharge after 4-hour observation: | ||
**Asymptomatic patients with small/accidental ingestion (e.g. taste of ant bait, accidental oral ingestion of vaginal suppository) | **Asymptomatic patients with small/accidental ingestion (e.g. taste of ant bait, accidental oral ingestion of vaginal suppository) | ||
**Ensure adequate oral hydration at discharge | **Ensure adequate oral hydration at discharge | ||
**Return precautions for delayed rash, GI symptoms, decreased urine output | **Return precautions for delayed rash, GI symptoms, decreased urine output | ||
* | *Admit: | ||
**Any symptomatic patient (GI symptoms, rash, neurologic changes) | **Any symptomatic patient (GI symptoms, rash, neurologic changes) | ||
**Large intentional ingestions regardless of initial symptoms | **Large intentional ingestions regardless of initial symptoms | ||
| Line 113: | Line 113: | ||
**Evidence of renal impairment, metabolic acidosis, or hepatic injury | **Evidence of renal impairment, metabolic acidosis, or hepatic injury | ||
**Suspected corrosive injury requiring endoscopy | **Suspected corrosive injury requiring endoscopy | ||
* | *ICU admission: | ||
**Seizures, altered mental status, cardiovascular instability | **Seizures, altered mental status, cardiovascular instability | ||
**Renal failure requiring dialysis | **Renal failure requiring dialysis | ||
**Multiorgan dysfunction | **Multiorgan dysfunction | ||
* | *Psychiatric evaluation: For all intentional ingestions after medical stabilization | ||
* | *Poison Control: Consult for all significant exposures — 1-800-222-1222 | ||
==See Also== | ==See Also== | ||
Latest revision as of 09:30, 22 March 2026
Background
- Boron toxicity results from exposure to boron-containing compounds, most commonly boric acid (H₃BO₃) and borax (sodium tetraborate decahydrate)[1]
- Common sources of exposure:
- Insecticides/pesticides (ant baits, cockroach powder — most common source in the ED)
- Vaginal suppositories (boric acid — accidental oral ingestion reported)
- Laundry products and cleaning agents (borax)
- Antiseptic solutions and wound care products (historical use)
- Industrial products (flame retardants, glass manufacturing, welding fluxes)
- Homemade "slime" products (borax-containing)
- Routes: oral ingestion (most common and most dangerous), dermal (through compromised skin), inhalation (occupational dust)
- Boric acid is readily absorbed from the GI tract (92–94% bioavailability); absorption through intact skin is minimal, but compromised skin (burns, wounds, diaper rash) allows significant systemic absorption[1]
- Excreted primarily via the kidneys; ~50% of an oral dose eliminated within 12 hours[2]
- Estimated minimum lethal oral dose of boric acid:[3]
- Infants: 2–3 g
- Children: 5–6 g
- Adults: 15–20 g
- However, a review of 784 boric acid poisonings (10–88 g ingested) found 88% were asymptomatic and no fatalities, indicating significant individual variability[3]
- There is no specific antidote — treatment is supportive with aggressive IV hydration
- Special populations at highest risk:
- Neonates/infants: Extremely low lethal dose; historical nursery epidemics from boric acid wound care caused multiple deaths
- Patients with renal impairment: Impaired clearance increases risk of toxic accumulation
- Burn patients / compromised skin: Systemic absorption through damaged skin can be fatal
Clinical Features
Acute Ingestion
- Gastrointestinal (earliest and most common):
- Nausea, vomiting (classically blue-green emesis), diarrhea (may also be blue-green), abdominal pain
- GI mucosal erosion/corrosive injury in large ingestions[4]
- Dermatologic (characteristic):
- Diffuse erythematous rash on palms, soles, and buttocks — classically described as "boiled lobster" appearance[3]
- Skin desquamation/exfoliation (may appear 1–2 days after exposure)
- Alopecia (with chronic exposure)
- Neurologic (severe toxicity):
- Headache, irritability, lethargy → tremor → seizures → coma
- Renal: Oliguria, acute renal failure
- Hepatic: Transaminitis, hepatic injury[4]
- Cardiovascular (severe): Hypotension, cardiovascular collapse
- Metabolic: Metabolic acidosis
- Death results from respiratory failure, cardiovascular collapse, or multiorgan failure[3]
Timing
- GI symptoms typically appear within 1–4 hours of ingestion
- If asymptomatic at 4 hours post-ingestion, significant toxicity from a single acute ingestion is unlikely
- Dermatologic findings may be delayed 1–2 days
Dermal Exposure
- Intact skin: minimal systemic absorption; local irritation possible
- Compromised skin: systemic absorption can occur and has been fatal in infants[1]
Inhalation
- Borate dust → nasal/throat irritation, cough; systemic toxicity from inhalation alone is rare
Differential Diagnosis
- Other caustic/corrosive ingestions (alkali, acid)
- Copper sulfate toxicity (also causes blue-green emesis)
- Iron toxicity (GI hemorrhage, metabolic acidosis, multiorgan failure)
- Paraquat toxicity (corrosive injury with hepatorenal and pulmonary failure)[4]
- Arsenic toxicity (GI symptoms, multiorgan failure)
- Erythroderma from other causes (drug reaction, staphylococcal scalded skin syndrome, TEN)
- Methanol toxicity, Ethylene glycol toxicity (metabolic acidosis with organ damage)
- Viral gastroenteritis (mild cases)
Evaluation
Workup
- Fingerstick glucose — all patients with altered mental status
- BMP/CMP: Electrolytes, BUN/creatinine (renal function), glucose, bicarbonate (acidosis), liver enzymes
- CBC
- ABG/VBG: If metabolic acidosis suspected
- Urinalysis: Assess renal function
- ECG: Baseline; monitor for dysrhythmias
- CXR: If respiratory symptoms present
- Acetaminophen, salicylate levels: Screen for co-ingestants in all intentional ingestions
- Serum boron level:
- Can confirm exposure but is not widely available in most EDs
- Should NOT guide acute management — treat based on clinical presentation[2]
- Levels > 340 μg/mL have been associated with fatalities
- Endoscopy: Consider if large ingestion with suspected corrosive injury to esophagus/stomach (consult GI)[4]
Diagnosis
- Diagnosis is primarily clinical — based on history of exposure and characteristic findings (blue-green emesis, "boiled lobster" rash, GI symptoms)
- Serum boron levels confirm exposure but do not correlate reliably with severity and should not delay treatment
- Activated charcoal does NOT effectively adsorb boric acid — a negative charcoal response does not exclude the diagnosis[1]
- Standard urine drug screens do not detect boron compounds
- Consider boron toxicity in unexplained erythroderma + GI symptoms, particularly in neonates/infants or patients with occupational/household exposure history
Management
- Airway: Protect if altered mental status; intubate for respiratory failure
- IV fluid resuscitation: This is the most important intervention — aggressive hydration enhances renal boron excretion (primary elimination pathway)[2]
- Target urine output > 2 mL/kg/hr
- Continuous cardiac monitoring and pulse oximetry
- GI decontamination:
- Activated charcoal is NOT effective for boric acid (poorly adsorbed)[1]
- Gastric lavage: Consider only for massive recent ingestions (within 1 hour) in symptomatic patients; not routinely recommended
- Whole bowel irrigation: May be considered for very large ingestions; limited evidence
- Dermal decontamination: Thorough irrigation with copious water; remove contaminated clothing
- Seizures: Benzodiazepines (lorazepam 0.1 mg/kg IV, or diazepam)
- Hypotension: IV fluid bolus; vasopressors (norepinephrine) if refractory
- Metabolic acidosis: Sodium bicarbonate if pH < 7.1 or hemodynamically significant
- Hemodialysis:[3]
- Effectively removes boron (small molecule, low protein binding, low volume of distribution)
- Indications: Massive ingestion, renal failure limiting excretion, severe or worsening toxicity despite supportive care
- Consider early in severe cases rather than as a rescue measure
Disposition
- Discharge after 4-hour observation:
- Asymptomatic patients with small/accidental ingestion (e.g. taste of ant bait, accidental oral ingestion of vaginal suppository)
- Ensure adequate oral hydration at discharge
- Return precautions for delayed rash, GI symptoms, decreased urine output
- Admit:
- Any symptomatic patient (GI symptoms, rash, neurologic changes)
- Large intentional ingestions regardless of initial symptoms
- Pediatric patients with estimated ingestion > 200 mg/kg boric acid
- Evidence of renal impairment, metabolic acidosis, or hepatic injury
- Suspected corrosive injury requiring endoscopy
- ICU admission:
- Seizures, altered mental status, cardiovascular instability
- Renal failure requiring dialysis
- Multiorgan dysfunction
- Psychiatric evaluation: For all intentional ingestions after medical stabilization
- Poison Control: Consult for all significant exposures — 1-800-222-1222
See Also
External Links
- Toxicity of boric acid, borax and other boron containing compounds - Regul Toxicol Pharmacol 2021
- Toxicological Profile for Boron: Health Effects - ATSDR (NCBI)
- Life-threatening corrosive injury in boric acid poisoning - Postgrad Med J 2022
- Borates, borax, and boric acid - Poison Control
- Unintentional boric acid exposure: case report with boron level monitoring - Ital J Pediatr 2025
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Hadrup N, Frederiksen M, Sharma AK. Toxicity of boric acid, borax and other boron containing compounds: a review. Regul Toxicol Pharmacol. 2021;121:104873. PMID 33485927.
- ↑ 2.0 2.1 2.2 Gasparini S, Donà C, Piccini E, et al. Unintentional boric acid exposure: a case report and boron level monitoring. Ital J Pediatr. 2025;51:148. PMID 40399389.
- ↑ 3.0 3.1 3.2 3.3 3.4 Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Boron. Atlanta, GA: US Department of Health and Human Services; 2010.
- ↑ 4.0 4.1 4.2 4.3 Singh H, Dhibar DP, Naidu GSRSNK. Life-threatening corrosive injury with hepato-renal-pulmonary failure in boric acid poisoning. Postgrad Med J. 2022;98(1155):70-71. PMID 33472901.
